MYP_053320
Basic Information
PTPRJ-pep19.5
Anticancer
Anticancer Cytotoxic anticancer activity Cytotoxic
Antimicrobial
Toxicity / Safety Blood cell toxicity Hemolysis Hemolytic
Toxicity / Safety Cytotoxicity Cytotoxic
Venom / Toxin General toxin Cytotoxic
Standard
9 amino acids
C38H56N16O12S2
Standard
Sequence
CHHNATHAC
Physicochemical Analysis
993.08 Da
7.00
0.00
-0.38
0.0002
-0.58
0.23
-0.02
120.24
22.22
0.0000
0.00
125.00
The radar chart summarizes major physicochemical dimensions for quick comparison, while exact numerical values remain listed on the left.
Residue Composition
Amino Acid Composition
Chemical Descriptors
445.48
-6.67
17.0
17.0
28.0
68.0
3.0
9.0
Structural Visualization
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber in the current view mode. Use the buttons to zoom.
2D CHEMICAL STRUCTURE
Drag to move
Drag to move. Use the buttons to zoom.
Experimental Records
RECORD: Rec_0261876 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
32630
Structure & Mods
cyclic/stapled peptide [Cyclic]
canonical L-amino-acid peptide [L]
None
None
Bio-Activity Profile
Antimicrobial Anticancer
HeLa
2±1.5 %
Inhibition
RECORD: Rec_0308141 VERIFIED: YES
Provenance & Taxonomy
Homo sapiens [Animal]
PTPRJ agonist peptide
9606
Structure & Mods
disulfide-constrained cyclic peptide [Cyclic]
canonical L-amino-acid peptide [L]
None
None
1-9
Bio-Activity Profile
Anticancer Cytotoxic
HeLa
160 μM
Inhibition
RECORD: Rec_0383353 VERIFIED: YES
Provenance & Taxonomy
not reported [other]
Structure & Mods
cyclic peptide; DSSP H 33.3%, E 0.0%, T 33.3%, C 33.3% [Cyclic]
canonical L-amino-acid peptide [L]
None
None
1-9
Bio-Activity Profile
Anticancer
Showing 3 records on this page · Page 2 of 2